# FDA EIR - The Procter & Gamble Manufacturing Company - March 10, 2023

Source: https://www.globalkeysolutions.net/records/eir/the-procter-gamble-manufacturing-company/48610638-4d54-409d-a30b-edb795ac7c79

> FDA EIR for The Procter & Gamble Manufacturing Company on March 10, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: The Procter & Gamble Manufacturing Company
- Inspection Date: 2023-03-10
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations II

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/derrick-elixson/0cee30ae-50c2-4c06-9049-76c682de7e33)
- [company_representative](https://www.globalkeysolutions.net/people/rashawnda-jenkins/259290ed-10e1-4a7e-9b87-e182cb6217c7)
- [Investigator](https://www.globalkeysolutions.net/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36)
- [company_representative](https://www.globalkeysolutions.net/people/lori-dahlin/3be92753-1cb7-44f3-8035-52626c406196)
- [company_representative](https://www.globalkeysolutions.net/people/joe-chang/43170f8a-9e0f-4546-bad4-96975409935f)

Company: https://www.globalkeysolutions.net/companies/the-procter-gamble-manufacturing-company/ceebac3f-c234-4225-b666-964153cdba97

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-ii/930d696b-0ac7-4de4-8268-e3db00525bc6